• Haris Vukas, Dragan Piljic, Samra Kadić-Vukas, and Dilista Piljic.
• From the Department of Vascular Surgery (Vukas), from the Department of Neurology (Kadić-Vukas), Cantonal Hospital Zenica, Zenica; from the Department of Vascular Surgery (Dragan Piljic), Cardiovascular Surgery Clinic, and from the Intensive Care (Dilista Piljic), University Clinical Center Tuzla, Clinic of Infective Disease, Tuzla, Bosnia and Herzegovina.
• Saudi Med J. 2021 Feb 1; 42 (2): 166-169.

ObjectivesTo avoid hospital spread of Coronavirus-2019 (COVID-19) and to analyze out of hospital outcomes after amputation.MethodsProspective analysis of data obtained from 60 diabetic patients in 2020 was performed at Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina. Personal protection equipment included double surgical mask, glasses, disposable surgical coats, and surgical masks for patients. Swabs were used to take samples from wounds. We randomly divided patients in 2 groups of 30 patients each. In pre-operative treatment, we used local anesthesia lidocaine hydrochloride 2% (Belupo, Koprivnica, Croatia) in group A and systemic analgesia intravenous tramadol chloride 100 mg intravenous (Krka, Novo Mesto, Slovenia) in group B. Wounds were surgically treated each day and heal spontaneously. Periodical control exams were performed.ResultsWound healing did not present any statistically significant differences between groups (group A: 69±21.97 and B: 61±22.13 days, t=-1.22; p=0.11). No statistically significant differences (p<0.05) between groups A and B in wound healing regarding to gender or cigarette use was noted.ConclusionNo significant differences in amputation treatment between the 2 comparative groups were noted. No confirmed COVID-19 infections in medical staff who performed surgical interventions or in treated patients were detected.Copyright: © Saudi Medical Journal.

25 keywords...

hide…